»Ê¼Ò»ªÈË

This fellowship will enhance the knowledge and practical skills of pathologists whose focus of clinical work, research and education involves skeletal disease such as primary bone tumours, skeletal dysplasia, and metabolic disease.

This scheme supports large-scale clinical trials that have significant potential to improve the survival for those affected by the hardest-to-treat blood cancers.

This grant funds research into chronic intestinal pseudo-obstruction (CIPO), dysmotility, gastroparesis and resultant intestinal failure.

Bowel Research UK welcome applications from clinical and non-clinical researchers investigating all topics within bowel disease.

Funding of up to £100,000 is available to provide additional support for clinical trials. The trials may be observational or interventional and may relate to either surgery or oncology.

This funding scheme helps UK-based primary bone cancer researchers to travel to national or international conferences.

The Bone Cancer Research Trust welcomes application for research into the treatment of the commonest bone sarcoma, chondrosarcoma.

Applications for funding of up to £150,000 are invited to support 4-year academic PhD studentships. Projects may focus on any or multiple forms of primary bone cancer; quality-of-life or epidemiology-based projects will not be considered. Part funding for projects already in progress will also not be considered. Projects should demonstrate a clear line of sight to patient benefit irrespective of how long this may take. Funding is available to researchers working in a UK institute. However, in...

Children’s Cancer and Leukaemia Group (CCLG) and The Bone Cancer Research Trust are funding research focused on Ewing sarcoma and osteosarcoma.

These Transformational Research Awards support advanced pre-clinical translational research, clinical studies or trials to develop and test new treatments, diagnostics or other technologies, or for the establishment of the evidence required for the uptake of improved treatments or technologies into the NHS. Research funded through this scheme should aim to accelerate progress towards a transformational change in prevention, diagnosis, treatment, or care for people affected by blood cancer.